11. Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial. Issue 23 (8th December 2020) Authors: Cosentino, Francesco; Cannon, Christopher P.; Cherney, David Z.I.; Masiukiewicz, Urszula; Pratley, Richard; Dagogo-Jack, Sam; Frederich, Robert; Charbonnel, Bernard; Mancuso, James; Shih, Weichung J.; Terra, Steven G.; Cater, Nilo B.; Gantz, Ira; McGuire, Darren K. Journal: Circulation Issue: Volume 142:Issue 23(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme. Issue 8 (13th May 2020) Authors: Thethi, Tina K.; Pratley, Richard; Meier, Juris J. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 8(2020) Page Start: 1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. Issue 8 (14th November 2021) Authors: Lam, Carolyn S.P.; Ramasundarahettige, Chinthanie; Branch, Kelley R.H.; Sattar, Naveed; Rosenstock, Julio; Pratley, Richard; Del Prato, Stefano; Lopes, Renato D.; Niemoeller, Elisabeth; Khurmi, Nardev S.; Baek, Seungjae; Gerstein, Hertzel C. Journal: Circulation Issue: Volume 145:Issue 8(2022) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. Issue 8 (22nd February 2022) Authors: Lam, Carolyn S.P.; Ramasundarahettige, Chinthanie; Branch, Kelley R.H.; Sattar, Naveed; Rosenstock, Julio; Pratley, Richard; Del Prato, Stefano; Lopes, Renato D.; Niemoeller, Elisabeth; Khurmi, Nardev S.; Baek, Seungjae; Gerstein, Hertzel C. Journal: Circulation Issue: Volume 145:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial. Issue 9 (September 2021) Authors: Cherney, David Z.I.; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K.; Pratley, Richard; Frederich, Robert; Maldonado, Mario; Liu, Chih-Chin; Liu, Jie; Pong, Annpey; Cannon, Christopher P. Other Names: author non-byline.; Pozzi Jose Maria author non-byline.; Maffei Laura author non-byline.; Nardone Lucrecia author non-byline.; Sessa Horacio author non-byline.; Brasca Daniela Garcia author non-byline.; Aizenberg Diego author non-byline.; Baccaro Claudia Emilce author non-byline.; Gelersztein El... Journal: Clinical journal of the American Society of Nephrology Issue: Volume 16:Issue 9(2021) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. Issue 13 (20th February 2023) Authors: Gerstein, Hertzel C.; Li, Zhuoru; Ramasundarahettige, Chinthanie; Baek, Seungjae; Branch, Kelley R.H.; Del Prato, Stefano; Lam, Carolyn S.P.; Lopes, Renato D.; Pratley, Richard; Rosenstock, Julio; Sattar, Naveed Journal: Circulation Issue: Volume 147:Issue 13(2023) Page Start: 1004 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease. (3rd May 2022) Authors: Perkovic, Vlado; Baeres, Florian; Bakris, George; Bosch-Traberg, Heidrun; Idorn, Thomas; Mahaffey, Kenneth; Mann, Johannes; Mersebach, Henriette; Rossing, Peter; Tuttle, Katherine; Pratley, Richard Journal: Nephrology dialysis transplantation Issue: Volume 37(2022)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. FP482EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER. (13th June 2019) Authors: Perkovic, Vlado; Bain, Stephen; Bakris, George; Buse, John; Gondolf, Theis; Idorn, Thomas; Lausvig, Nanna; Mahaffey, Kenneth; Marso, Steven; Nauck, Michael; Pratley, Richard; Rossing, Peter; Zinman, Bernard; Mann, Johannes Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. FP483EFFECTS OF SEMAGLUTIDE AND LIRAGLUTIDE ON URINARY ALBUMIN-TO-CREATININE RATIO (UACR) – A POOLED ANALYSIS OF SUSTAIN 6 AND LEADER. (13th June 2019) Authors: Perkovic, Vlado; Bain, Stephen; Bakris, George; Buse, John; Idorn, Thomas; Mahaffey, Kenneth; Marso, Steven; Nauck, Michael; Pratley, Richard; Rasmussen, Søren; Rossing, Peter; Tornoe, Karen; Zinman, Bernard; Mann, Johannes Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations From VERTIS CV. Issue 6 (9th February 2021) Authors: Cherney, David Z.I.; McGuire, Darren K.; Charbonnel, Bernard; Cosentino, Francesco; Pratley, Richard; Dagogo-Jack, Samuel; Frederich, Robert; Maldonado, Mario; Liu, Jie; Pong, Annpey; Liu, Chih-Chin; Cannon, Christopher P. Journal: Circulation Issue: Volume 143:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗